Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
BIOG-B.STthis companyBioGaia AB (publ)	SEK 124.30	32.28×	8.17×	6.98×	21.9×	-10.4%	73.4%	26.8%	21.6%	25.3%	23.2%	2.8%	0.01×	-1.75×	48.84×	6.12×	6.5%	5	33.6	3	B+
ENZY.STEnzymatica AB (publ)	SEK 2.40	-9.05×	3.71×	8.56×	-9.17×	-287.0%	61.5%	-96.9%	-96.3%	-41.8%	-41.7%	-8.9%	0.01×	0.69×	-42.41×	3.65×	0.0%	4	10.82	1	C-
HUMBLE.STHumble Group AB (publ)	SEK 6.10	204.75×	0.71×	0.43×	9.6×	-1619.3%	4.0%	3.5%	0.2%	0.3%	0.9%	8.5%	0.56×	3.95×	1.64×	1.54×	0.0%	4	1.29	2	B-
MSON-B.STMidsona AB (publ)	SEK 9.02	123.26×	0.42×	0.34×	7.44×	304.2%	28.5%	3.7%	0.3%	0.3%	1.4%	16.3%	0.21×	1.45×	3.44×	2.1×	2.4%	6	1.82	4	A-
NNH.STNew Nordic Healthbrands AB	SEK 15.05	17.58×	1.39×	0.25×	9.26×	-27.5%	2.8%	2.6%	1.4%	7.9%	7.1%	5.3%	0.35×	1.1×	5.65×	1.6×	0.0%	3	2.82	3	B+
ZZ-B.STZinzino AB (publ)	SEK 113.80	17.51×	8.03×	1.79×	16.18×	32.8%	8.6%	8.6%	10.2%	45.9%	25.2%	9.3%	0.06×	-2.38×	77.28×	1.4×	2.5%	6	5.3	5	A+
Peer median	—	17.58×	1.39×	0.43×	9.26×	-27.5%	8.6%	3.5%	0.3%	0.3%	1.4%	8.5%	0.21×	1.1×	3.44×	1.6×	0.0%	4	2.82	3	—